WCN26-7011 RISK OF MAJOR ADVERSE CARDIOVASCULAR OUTCOME AMONG CHILDHOOD CANCER SURVIVORS WITH CHRONIC KIDNEY DISEASE OR HYPERTENSION
Katrina Anne Cordova(Hospital for Sick Children), Atessa Bahadori(Hospital for Sick Children), Tal Schechter(Hospital for Sick Children), Laura Wheaton(Kingston Health Sciences Centre), Abhijat Kitchlu(University Health Network), Nithiakishna Selvathesan(University of Toronto), Lillian Sung(Hospital for Sick Children), Asaf Lebel(Technion – Israel Institute of Technology), Serina Patel(Children's Hospital of Western Ontario), Samuel Silver(Queen's University), Paul Nathan(Hospital for Sick Children), Amit Garg(Institute for Clinical Evaluative Sciences), Rahul Chanchlani(McMaster Children's Hospital), Ron Wald(St. Michael's Hospital), Eric McArthur(Institute for Clinical Evaluative Sciences)
Cited by 0
Related Papers
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383
Sustainable care for children with cancer: a Lancet Oncology Commission
|The Lancet Oncology|2020|346
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial
|The Lancet Oncology|2016|255
Ethnic Differences in Childhood Nephrotic Syndrome
|Frontiers in Pediatrics|2016|154